DrugPatentWatch Database Preview
ANTHELIOS 20 Drug Profile
When do Anthelios 20 patents expire, and when can generic versions of Anthelios 20 launch?
The generic ingredient in ANTHELIOS 20 is avobenzone; ecamsule; octocrylene; titanium dioxide. There are two drug master file entries for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene; titanium dioxide profile page.
Summary for ANTHELIOS 20
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | ANTHELIOS 20 at DailyMed |
US Patents and Regulatory Information for ANTHELIOS 20
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loreal Usa | ANTHELIOS 20 | avobenzone; ecamsule; octocrylene; titanium dioxide | CREAM;TOPICAL | 021471-001 | Oct 5, 2006 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
